Acetyl Gastric Inhibitory Peptide (human) (TFA) (Synonyms: Human N-acetyl GIP TFA) |
Katalog-Nr.GC68604 |
Acetyl Gastric Inhibitory Peptid (human) TFA ist ein fettähnliches Derivat des glukoseabhängigen Insulin-Polypeptids mit verbesserten antihyperglykämischen und insulinotropen Eigenschaften. Acetyl Gastric Inhibitory Peptide (human) TFA kann für die Erforschung von Diabetes, Insulinresistenz und Fettleibigkeit verwendet werden.
Products are for research use only. Not for human use. We do not sell to patients.
Sample solution is provided at 25 µL, 10mM.
Review for Acetyl Gastric Inhibitory Peptide (human) (TFA)
Average Rating: 5
(Based on Reviews and 30 reference(s) in Google Scholar.)Review for Acetyl Gastric Inhibitory Peptide (human) (TFA)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *